Atomistry » Iron » PDB 3qjt-3r0g » 3qoa
Atomistry »
  Iron »
    PDB 3qjt-3r0g »
      3qoa »

Iron in PDB 3qoa: Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.

Enzymatic activity of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.

All present enzymatic activity of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.:
1.14.14.1;

Protein crystallography data

The structure of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine., PDB code: 3qoa was solved by M.B.Shah, J.Pascual, C.D.Stout, J.R.Halpert, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.34 / 2.10
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 76.760, 76.760, 201.341, 90.00, 90.00, 120.00
R / Rfree (%) 19.7 / 25

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine. (pdb code 3qoa). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total only one binding site of Iron was determined in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine., PDB code: 3qoa:

Iron binding site 1 out of 1 in 3qoa

Go back to Iron Binding Sites List in 3qoa
Iron binding site 1 out of 1 in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe500

b:17.6
occ:1.00
FE A:HEM500 0.0 17.6 1.0
NA A:HEM500 1.8 18.0 1.0
NB A:HEM500 1.9 20.5 1.0
NC A:HEM500 2.0 16.8 1.0
ND A:HEM500 2.1 19.2 1.0
SG A:CYS436 2.3 16.4 1.0
NAK A:3QO501 2.4 35.8 1.0
C1A A:HEM500 2.9 17.2 1.0
C4A A:HEM500 2.9 14.2 1.0
C4C A:HEM500 3.0 16.0 1.0
C4B A:HEM500 3.0 17.2 1.0
C1B A:HEM500 3.0 17.9 1.0
C1C A:HEM500 3.0 14.5 1.0
C4D A:HEM500 3.0 17.8 1.0
CAE A:3QO501 3.0 34.2 1.0
C1D A:HEM500 3.1 16.1 1.0
CB A:CYS436 3.2 18.6 1.0
CHA A:HEM500 3.3 19.0 1.0
CAD A:3QO501 3.3 33.8 1.0
CHB A:HEM500 3.3 16.4 1.0
CHC A:HEM500 3.3 15.3 1.0
CHD A:HEM500 3.3 14.9 1.0
CA A:CYS436 4.0 17.4 1.0
C3A A:HEM500 4.1 11.9 1.0
C2A A:HEM500 4.1 14.2 1.0
C3C A:HEM500 4.1 15.6 1.0
C3B A:HEM500 4.2 15.1 1.0
C2C A:HEM500 4.2 17.3 1.0
C2B A:HEM500 4.2 16.7 1.0
C3D A:HEM500 4.3 12.5 1.0
C2D A:HEM500 4.3 17.6 1.0
CAI A:3QO501 4.4 31.5 1.0
CAH A:3QO501 4.6 31.3 1.0
C A:CYS436 4.7 17.7 1.0
N A:GLY438 4.7 14.6 1.0
N A:LEU437 4.7 17.0 1.0
CG2 A:THR302 4.9 22.2 1.0
CAM A:3QO501 5.0 31.5 1.0

Reference:

M.B.Shah, J.Pascual, Q.Zhang, C.D.Stout, J.R.Halpert. Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)Pyridine: Insight Into Inhibitor Binding and Rearrangement of Active Site Side Chains. Mol.Pharmacol. V. 80 1047 2011.
ISSN: ISSN 0026-895X
PubMed: 21875942
DOI: 10.1124/MOL.111.074427
Page generated: Sun Aug 4 18:52:46 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy